0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Prothrombin Complex Market Research Report 2026
Published Date: 2026-01-23
|
Report Code: QYRE-Auto-36M446
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Human Prothrombin Complex Market Insights and Forecast to 2028
BUY CHAPTERS

Global Human Prothrombin Complex Market Research Report 2026

Code: QYRE-Auto-36M446
Report
2026-01-23
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Prothrombin Complex Market Size

The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.

Human Prothrombin Complex Market

Human Prothrombin Complex Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Human Prothrombin Complex competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
This report delivers a comprehensive overview of the global Human Prothrombin Complex market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human Prothrombin Complex. The Human Prothrombin Complex market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Human Prothrombin Complex market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human Prothrombin Complex manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Human Prothrombin Complex Market Report

Report Metric Details
Report Name Human Prothrombin Complex Market
Accounted market size in 2025 US$ 2177 million
Forecasted market size in 2032 US$ 4702 million
CAGR 11.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 500 IU/Vial
  • 600 IU/Vial
  • 1000 IU/Vial
  • Others
by Application
  • Hemophilia B
  • Vitamin K Deficiency
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Human Prothrombin Complex manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Human Prothrombin Complex sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Human Prothrombin Complex Market growing?

Ans: The Human Prothrombin Complex Market witnessing a CAGR of 11.8% during the forecast period 2026-2032.

What is the Human Prothrombin Complex Market size in 2032?

Ans: The Human Prothrombin Complex Market size in 2032 will be US$ 4702 million.

What is the market share of major companies in Human Prothrombin Complex Market?

Ans: Global top three manufacturers hold a share over 75%.

What is the Human Prothrombin Complex Market share by type?

Ans: In terms of product, 500 IU/Vial is the largest segment, with a share over 50%.

Who are the main players in the Human Prothrombin Complex Market report?

Ans: The main players in the Human Prothrombin Complex Market are Takeda, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma

What are the Application segmentation covered in the Human Prothrombin Complex Market report?

Ans: The Applications covered in the Human Prothrombin Complex Market report are Hemophilia B, Vitamin K Deficiency, Others

What are the Type segmentation covered in the Human Prothrombin Complex Market report?

Ans: The Types covered in the Human Prothrombin Complex Market report are 500 IU/Vial, 600 IU/Vial, 1000 IU/Vial, Others

1 Human Prothrombin Complex Market Overview
1.1 Product Definition
1.2 Human Prothrombin Complex by Type
1.2.1 Global Human Prothrombin Complex Market Value by Type: 2025 vs 2032
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Human Prothrombin Complex by Application
1.3.1 Global Human Prothrombin Complex Market Value by Application: 2025 vs 2032
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Global Human Prothrombin Complex Market Size Estimates and Forecasts
1.4.1 Global Human Prothrombin Complex Revenue 2021–2032
1.4.2 Global Human Prothrombin Complex Sales 2021–2032
1.4.3 Global Human Prothrombin Complex Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Human Prothrombin Complex Market Competition by Manufacturers
2.1 Global Human Prothrombin Complex Sales Market Share by Manufacturers (2021–2026)
2.2 Global Human Prothrombin Complex Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Human Prothrombin Complex Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Human Prothrombin Complex, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Human Prothrombin Complex, Product Types and Applications
2.7 Global Key Manufacturers of Human Prothrombin Complex, Date of Entry into the Industry
2.8 Global Human Prothrombin Complex Market Competitive Situation and Trends
2.8.1 Global Human Prothrombin Complex Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Human Prothrombin Complex Players Market Share by Revenue
2.8.3 Global Human Prothrombin Complex Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Prothrombin Complex Market Scenario by Region
3.1 Global Human Prothrombin Complex Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Human Prothrombin Complex Sales by Region: 2021–2032
3.2.1 Global Human Prothrombin Complex Sales by Region: 2021–2026
3.2.2 Global Human Prothrombin Complex Sales by Region: 2027–2032
3.3 Global Human Prothrombin Complex Revenue by Region: 2021–2032
3.3.1 Global Human Prothrombin Complex Revenue by Region: 2021–2026
3.3.2 Global Human Prothrombin Complex Revenue by Region: 2027–2032
3.4 North America Human Prothrombin Complex Market Facts & Figures by Country
3.4.1 North America Human Prothrombin Complex Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Human Prothrombin Complex Sales by Country (2021–2032)
3.4.3 North America Human Prothrombin Complex Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Prothrombin Complex Market Facts & Figures by Country
3.5.1 Europe Human Prothrombin Complex Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Human Prothrombin Complex Sales by Country (2021–2032)
3.5.3 Europe Human Prothrombin Complex Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Prothrombin Complex Market Facts & Figures by Region
3.6.1 Asia Pacific Human Prothrombin Complex Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Human Prothrombin Complex Sales by Region (2021–2032)
3.6.3 Asia Pacific Human Prothrombin Complex Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Prothrombin Complex Market Facts & Figures by Country
3.7.1 Latin America Human Prothrombin Complex Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Human Prothrombin Complex Sales by Country (2021–2032)
3.7.3 Latin America Human Prothrombin Complex Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Prothrombin Complex Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Prothrombin Complex Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Human Prothrombin Complex Sales by Country (2021–2032)
3.8.3 Middle East and Africa Human Prothrombin Complex Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Prothrombin Complex Sales by Type (2021–2032)
4.1.1 Global Human Prothrombin Complex Sales by Type (2021–2026)
4.1.2 Global Human Prothrombin Complex Sales by Type (2027–2032)
4.1.3 Global Human Prothrombin Complex Sales Market Share by Type (2021–2032)
4.2 Global Human Prothrombin Complex Revenue by Type (2021–2032)
4.2.1 Global Human Prothrombin Complex Revenue by Type (2021–2026)
4.2.2 Global Human Prothrombin Complex Revenue by Type (2027–2032)
4.2.3 Global Human Prothrombin Complex Revenue Market Share by Type (2021–2032)
4.3 Global Human Prothrombin Complex Price by Type (2021–2032)
5 Segment by Application
5.1 Global Human Prothrombin Complex Sales by Application (2021–2032)
5.1.1 Global Human Prothrombin Complex Sales by Application (2021–2026)
5.1.2 Global Human Prothrombin Complex Sales by Application (2027–2032)
5.1.3 Global Human Prothrombin Complex Sales Market Share by Application (2021–2032)
5.2 Global Human Prothrombin Complex Revenue by Application (2021–2032)
5.2.1 Global Human Prothrombin Complex Revenue by Application (2021–2026)
5.2.2 Global Human Prothrombin Complex Revenue by Application (2027–2032)
5.2.3 Global Human Prothrombin Complex Revenue Market Share by Application (2021–2032)
5.3 Global Human Prothrombin Complex Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Human Prothrombin Complex Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Takeda Human Prothrombin Complex Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Human Prothrombin Complex Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 CSL Human Prothrombin Complex Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Company Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Human Prothrombin Complex Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Grifols Human Prothrombin Complex Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Human Prothrombin Complex Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Octapharma Human Prothrombin Complex Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Hualan Biological
6.5.1 Hualan Biological Company Information
6.5.2 Hualan Biological Description and Business Overview
6.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Hualan Biological Human Prothrombin Complex Product Portfolio
6.5.5 Hualan Biological Recent Developments/Updates
6.6 Meheco Xinxing Pharma
6.6.1 Meheco Xinxing Pharma Company Information
6.6.2 Meheco Xinxing Pharma Description and Business Overview
6.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
6.6.5 Meheco Xinxing Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Prothrombin Complex Industry Chain Analysis
7.2 Human Prothrombin Complex Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Prothrombin Complex Production Mode & Process Analysis
7.4 Human Prothrombin Complex Sales and Marketing
7.4.1 Human Prothrombin Complex Sales Channels
7.4.2 Human Prothrombin Complex Distributors
7.5 Human Prothrombin Complex Customer Analysis
8 Human Prothrombin Complex Market Dynamics
8.1 Human Prothrombin Complex Industry Trends
8.2 Human Prothrombin Complex Market Drivers
8.3 Human Prothrombin Complex Market Challenges
8.4 Human Prothrombin Complex Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Human Prothrombin Complex Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Human Prothrombin Complex Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Human Prothrombin Complex Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Human Prothrombin Complex Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Human Prothrombin Complex Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Human Prothrombin Complex Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Human Prothrombin Complex Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Human Prothrombin Complex Average Price (M USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Human Prothrombin Complex, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Human Prothrombin Complex, Product Types and Applications
 Table 12. Global Key Manufacturers of Human Prothrombin Complex, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Prothrombin Complex Companies by Tier (Tier 1, Tier 2, Tier 3), based on Human Prothrombin Complex Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Prothrombin Complex Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Human Prothrombin Complex Sales by Region (K Units), 2021–2026
 Table 18. Global Human Prothrombin Complex Sales Market Share by Region (2021–2026)
 Table 19. Global Human Prothrombin Complex Sales by Region (K Units), 2027–2032
 Table 20. Global Human Prothrombin Complex Sales Market Share by Region (2027–2032)
 Table 21. Global Human Prothrombin Complex Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Human Prothrombin Complex Revenue Market Share by Region (2021–2026)
 Table 23. Global Human Prothrombin Complex Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Human Prothrombin Complex Revenue Market Share by Region (2027–2032)
 Table 25. North America Human Prothrombin Complex Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Human Prothrombin Complex Sales by Country (K Units), 2021–2026
 Table 27. North America Human Prothrombin Complex Sales by Country (K Units), 2027–2032
 Table 28. North America Human Prothrombin Complex Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Human Prothrombin Complex Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Human Prothrombin Complex Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Human Prothrombin Complex Sales by Country (K Units), 2021–2026
 Table 32. Europe Human Prothrombin Complex Sales by Country (K Units), 2027–2032
 Table 33. Europe Human Prothrombin Complex Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Human Prothrombin Complex Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Human Prothrombin Complex Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Human Prothrombin Complex Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Human Prothrombin Complex Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Human Prothrombin Complex Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Human Prothrombin Complex Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Human Prothrombin Complex Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Human Prothrombin Complex Sales by Country (K Units), 2021–2026
 Table 42. Latin America Human Prothrombin Complex Sales by Country (K Units), 2027–2032
 Table 43. Latin America Human Prothrombin Complex Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Human Prothrombin Complex Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Human Prothrombin Complex Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Human Prothrombin Complex Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Human Prothrombin Complex Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Human Prothrombin Complex Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Human Prothrombin Complex Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Human Prothrombin Complex Sales (K Units) by Type (2021–2026)
 Table 51. Global Human Prothrombin Complex Sales (K Units) by Type (2027–2032)
 Table 52. Global Human Prothrombin Complex Sales Market Share by Type (2021–2026)
 Table 53. Global Human Prothrombin Complex Sales Market Share by Type (2027–2032)
 Table 54. Global Human Prothrombin Complex Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Human Prothrombin Complex Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Human Prothrombin Complex Revenue Market Share by Type (2021–2026)
 Table 57. Global Human Prothrombin Complex Revenue Market Share by Type (2027–2032)
 Table 58. Global Human Prothrombin Complex Price (M USD/Unit) by Type (2021–2026)
 Table 59. Global Human Prothrombin Complex Price (M USD/Unit) by Type (2027–2032)
 Table 60. Global Human Prothrombin Complex Sales (K Units) by Application (2021–2026)
 Table 61. Global Human Prothrombin Complex Sales (K Units) by Application (2027–2032)
 Table 62. Global Human Prothrombin Complex Sales Market Share by Application (2021–2026)
 Table 63. Global Human Prothrombin Complex Sales Market Share by Application (2027–2032)
 Table 64. Global Human Prothrombin Complex Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Human Prothrombin Complex Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Human Prothrombin Complex Revenue Market Share by Application (2021–2026)
 Table 67. Global Human Prothrombin Complex Revenue Market Share by Application (2027–2032)
 Table 68. Global Human Prothrombin Complex Price (M USD/Unit) by Application (2021–2026)
 Table 69. Global Human Prothrombin Complex Price (M USD/Unit) by Application (2027–2032)
 Table 70. Takeda Company Information
 Table 71. Takeda Description and Business Overview
 Table 72. Takeda Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit), and Gross Margin (2021–2026)
 Table 73. Takeda Human Prothrombin Complex Product
 Table 74. Takeda Recent Developments/Updates
 Table 75. CSL Company Information
 Table 76. CSL Description and Business Overview
 Table 77. CSL Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit), and Gross Margin (2021–2026)
 Table 78. CSL Human Prothrombin Complex Product
 Table 79. CSL Recent Developments/Updates
 Table 80. Grifols Company Information
 Table 81. Grifols Description and Business Overview
 Table 82. Grifols Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit), and Gross Margin (2021–2026)
 Table 83. Grifols Human Prothrombin Complex Product
 Table 84. Grifols Recent Developments/Updates
 Table 85. Octapharma Company Information
 Table 86. Octapharma Description and Business Overview
 Table 87. Octapharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit), and Gross Margin (2021–2026)
 Table 88. Octapharma Human Prothrombin Complex Product
 Table 89. Octapharma Recent Developments/Updates
 Table 90. Hualan Biological Company Information
 Table 91. Hualan Biological Description and Business Overview
 Table 92. Hualan Biological Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit), and Gross Margin (2021–2026)
 Table 93. Hualan Biological Human Prothrombin Complex Product
 Table 94. Hualan Biological Recent Developments/Updates
 Table 95. Meheco Xinxing Pharma Company Information
 Table 96. Meheco Xinxing Pharma Description and Business Overview
 Table 97. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit), and Gross Margin (2021–2026)
 Table 98. Meheco Xinxing Pharma Human Prothrombin Complex Product
 Table 99. Meheco Xinxing Pharma Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Human Prothrombin Complex Distributors List
 Table 103. Human Prothrombin Complex Customers List
 Table 104. Human Prothrombin Complex Market Trends
 Table 105. Human Prothrombin Complex Market Drivers
 Table 106. Human Prothrombin Complex Market Challenges
 Table 107. Human Prothrombin Complex Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Prothrombin Complex
 Figure 2. Global Human Prothrombin Complex Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Human Prothrombin Complex Market Share by Type: 2025 & 2032
 Figure 4. 500 IU/Vial Product Picture
 Figure 5. 600 IU/Vial Product Picture
 Figure 6. 1000 IU/Vial Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Human Prothrombin Complex Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Human Prothrombin Complex Market Share by Application: 2025 & 2032
 Figure 10. Hemophilia B
 Figure 11. Vitamin K Deficiency
 Figure 12. Others
 Figure 13. Global Human Prothrombin Complex Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Human Prothrombin Complex Market Size (US$ Million), 2021–2032
 Figure 15. Global Human Prothrombin Complex Sales (K Units), 2021–2032
 Figure 16. Global Human Prothrombin Complex Average Price (M USD/Unit), 2021–2032
 Figure 17. Human Prothrombin Complex Report Years Considered
 Figure 18. Human Prothrombin Complex Sales Share by Manufacturers in 2025
 Figure 19. Global Human Prothrombin Complex Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Human Prothrombin Complex Players: Market Share by Revenue in Human Prothrombin Complex in 2025
 Figure 21. Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Human Prothrombin Complex Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Human Prothrombin Complex Sales Market Share by Country (2021–2032)
 Figure 24. North America Human Prothrombin Complex Revenue Market Share by Country (2021–2032)
 Figure 25. U.S. Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Human Prothrombin Complex Sales Market Share by Country (2021–2032)
 Figure 28. Europe Human Prothrombin Complex Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Human Prothrombin Complex Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Human Prothrombin Complex Revenue Market Share by Region (2021–2032)
 Figure 36. China Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Indonesia Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Thailand Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Malaysia Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Latin America Human Prothrombin Complex Sales Market Share by Country (2021–2032)
 Figure 46. Latin America Human Prothrombin Complex Revenue Market Share by Country (2021–2032)
 Figure 47. Mexico Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Brazil Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Argentina Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Human Prothrombin Complex Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Human Prothrombin Complex Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. UAE Human Prothrombin Complex Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Human Prothrombin Complex by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Human Prothrombin Complex by Type (2021–2032)
 Figure 57. Global Human Prothrombin Complex Price (M USD/Unit) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Human Prothrombin Complex by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Human Prothrombin Complex by Application (2021–2032)
 Figure 60. Global Human Prothrombin Complex Price (M USD/Unit) by Application (2021–2032)
 Figure 61. Human Prothrombin Complex Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS